Table 5.
Description of FRS (2008) and heart age in ERA (ESPOIR) and ESpA (DESIR) men and women
| Gender | Age groups | ESPOIR Patients with ERA |
DESIR Patients with ESpA |
||||
|---|---|---|---|---|---|---|---|
| N | FRS 2008 mean±SD |
Heart age mean±SD |
N | FRS 2008 mean±SD |
Heart age mean±SD |
||
| Men | 30–34 | 3 | 4.2±1.4 | 39.7±4.7 | 54 | 3.0±1.4 | 35.4±4.8 |
| 35–39 | 12 | 5.0±2.7 | 41.3±6.8 | 40 | 4.1±2.3 | 39.0±6.6 | |
| 40–44 | 8 | 7.0±4.5 | 45.4±10.1 | 22 | 7.1±4.2 | 46.0±8.7 | |
| 45–49 | 3 | 7.4±1.3 | 49.0±3.5 | 30 | 10.0±5.3 | 51.8±10.2 | |
| 50–54 | 19 | 13.4±8.9 | 56.7±10.0 | – | – | – | |
| 55–59 | 14 | 20.0±12.9 | 63.7±10.5 | – | – | – | |
| 60–64 | 6 | 24.0±11.5 | 69.5±8.3 | – | – | – | |
| 65–69 | 7 | 25.2±10.1 | 70.9±8.6 | – | – | – | |
| Women | 30–34 | 22 | 1.2±0.3 | 32.8±1.5 | 58 | 1.5±1.0 | 33.9±4.5 |
| 35–39 | 22 | 1.8±0.8 | 36.6±4.2 | 58 | 2.3±1.5 | 38.0±7.1 | |
| 40–44 | 27 | 3.2±1.7 | 43.4±7.4 | 39 | 2.9±1.7 | 41.9±7.8 | |
| 45–49 | 36 | 5.0±2.5 | 50.6±10.1 | 32 | 4.1±1.7 | 47.6±8.0 | |
| 50–54 | 42 | 6.7±4.3 | 55.7±12.7 | – | – | – | |
| 55–59 | 48 | 9.0±4.9 | 63.0±12.5 | – | – | – | |
| 60–64 | 29 | 11.3±5.2 | 70.0±7.8 | – | – | – | |
| 65–69 | 15 | 15.2±11.3 | 70.0±11.3 | – | – | – | |
| Total | 313 | 8.3±8.0 | 54.2±15.1 | 333 | 3.7±3.4 | 40.1±8.9 | |
N, number with FRS calculated.
DESIR, Devenir des Spondylarthropathies Indifférenciées Récentes; ERA, early rheumatoid arthritis; ESpA, early axial spondyloarthritis; ESPOIR, Etude et Suivi des Polyarthrites Indifférenciées Récentes; FRS 2008, Framingham Risk Score (2008).